ML20154F409
| ML20154F409 | |
| Person / Time | |
|---|---|
| Site: | 03013158 |
| Issue date: | 12/10/1985 |
| From: | Riedlinger B NRC OFFICE OF INSPECTION & ENFORCEMENT (IE REGION V) |
| To: | Burns J BARTLETT MEMORIAL HOSP., JUNEAU, AK |
| Shared Package | |
| ML20154F297 | List: |
| References | |
| 70299, NUDOCS 8603070454 | |
| Download: ML20154F409 (2) | |
See also: IR 05000176/1986001
Text
r
'
-
,
..
-
5a
.
.
DEC 10 W
.
Docket No. : 030-13158
Licende No.:
50-17686-01
Control No.: 70299
Bartlett Memorial Hospital
3260 Hospital Drive
Juneau, Alaska 99801
Attention:
Mr. James R. Burns
Administrator
Gentlemen:
This is in reference to your application dated November 25, 1985 to amend your
byproduct material license. In order to complete our review, we need the
following additional information:
1.
You should submit documentation that Dr. Greening has completed 200
hours of didactic training as described in Item 2.a. of Appendix A to
Although the Supplement A which was submitted
with your letter dated November 25, 1985 does indicate that Dr. Greening
received training at the Hospital of the University of Pennsylvania, it
does not reflect the number of hours of didactic training received in
each of the five fields of training indicated on Supplement A.
,
2.
Although the NRC-313M Supplement B lists three hospitals where Dr.
Greening received training and experience, only one preceptor signature
is given.
Separate preceptor statements should be submitted from each
institution. These statements should indicate the extent of Dr.
Greening's involvement with the nuclear medicine programs. Refer to
Item 2.c. of Appendix A to Regulatory Guide 10.8,
If it is not possible to obtain preceptor statements from physicians who
supervised Dr. Greening during his internship, you should ask that each
of the three hospitals submit a signed statement to document:
the time interval when Dr. Greening was present at the f acility.
a.
b.
his involvement with the nuclear medicine program.
c.
the extent of his involvement (patient selection, dose
determination, scan interpretation, patient followup, study of
possible complications, etc.)
d.
any authorization granted to Dr. Greening by the hospital's
,
,
ames) . . . .R.V . [ . . g. . .m . m o m . m . . b....,m--.mlmm.
l
"'"""""'"
" " * " " " " " " " "
" " " " * " " " " " '
0603070454 060203
............
gg ,
.
REG 5 LIC30
- ME)
'" " " **" " "'****
" "***"'**********
o-
06-oi
..................
.................
Q
our) . ..12. ./.[ . ./.8. 5.. .
.....................l.....................l.....................l............................................................
a
= a m a n . aru na me na n u n
n E" E" I t'* l A I D E*(* M D r)
(* O PY
% U.S. GPO 1983-400-243
.
J'
.
DEC 101905
Bartlett Memorial Hospital
-2-
3.
In order to add Dr. Greening as an authorized user for Group III, we
must have documentation to verify that he has personally participated in
five procedures to elute technetium-99m including testing of elute,
and in five procedures to prepare radiopharmaceuticals from Group III
reagent kits. You should submit this documentation. Refer to Item 2b
of Appendix A to Regulatory Guide 10.8.
We will continue the review.uf your amendment request upon receipt of this
information. If we do not receive a reply from you within 30 calendar days
from the date of this letter, we shall assume that you do not wish to pursue
your application. Please reply in duplicate, and refer to Mail Control No.
70299.
Sincerely,
Beth A. Riedlinger
Health Physicist (Licensing)
Nuclear Materials Safety Section
Enclosures:
Appendix A to Regulatory Guide 10.8
Federal Register Notice dated December 2, 1982 (FR 54376)
t